Medical
Millennium BlockChain Closes $5 Million Strategic Investment in BurstIQ
Blockchain holding company to take equity position in leading U.S. based enterprise-level blockchain health data company PR Newswire LAS VEGAS...
Read more
MoneyTV with Donald Baillargeon, 4/20
LOS ANGELES, CA / ACCESSWIRE / April 20, 2018 / Cannabis business converging with cryptocurrency, organic teas, soursop fruit, Water chain,...
Read more
Precision Therapeutics, Inc. Engages Richard Gabriel to Drive Business Development Strategy for its TumorGenesis Subsidiary
Richard Gabriel, BS, MBA is a board member of Precision Therapeutics and spearheaded the licensing of new technologies for 3D...
Read more
Co-Diagnostics Files Initial Annual Report on Form 10-K and Updates Corporate Developments
CODX updates on initial six months as a public company SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics...
Read morePrecision Therapeutics Reports Fiscal Year 2017 Financial Results
Company reports strengthening STREAMWAY® System sales and new strategic focus on the emerging precision medicine market MINNEAPOLIS, April 02, 2018...
Read morePrecision Therapeutics Announces Record STREAMWAY® System Sales in the First Three Months of 2018
Sixteen STREAMWAY Systems sold in Q1 2018, compared with five units sold in Q4 2017 and three sold in Q1...
Read more
Vitality Biopharma Files Intellectual Property in All Major Pharmaceutical Markets Worldwide
THC prodrugs including VBX-100 designed to deliver cannabinoids for targeted therapeutic effects without psychoactivity LOS ANGELES, March 28, 2018 (GLOBE...
Read morePrecision Therapeutics to Hold Business Update Conference Call on April 2, 2018
MINNEAPOLIS, (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical, a company focused on applying artificial intelligence...
Read more
Immune Therapeutics, Inc. Received Minutes From FDA Meeting for Lodonal™ for the Treatment for Crohn’s Disease
ORLANDO, Fla., March 26, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Immune Therapeutics, Inc. (OTCQB:IMUN) ("Immune" "IMUN" or the...
Read morePrecision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge Incorporated
MINNEAPOLIS, March 21, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its...
Read morePrecision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with 48Hour Discovery
MINNEAPOLIS, March 15, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its...
Read moreCo-Diagnostics Inc Announces Positive Results from Co-Primers™ Technology in Multiplex Tests for SNP Detection
SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform...
Read morePrecision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models
MINNEAPOLIS, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical (NASDAQ:SKLN), a...
Read more
Titan Medical Granted Patent Related to Instrument End-Effector for Use in Robotic Surgery
TORONTO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on...
Read moreImmune Therapeutics, Inc. Announces First Sales & Shipment of Lodonal; Receives Trademark and Patent Approval From Federal Republic of Nigeria
ORLANDO, Fla., Feb. 20, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Immune Therapeutics, Inc. (OTCQB:IMUN) ("Immune" “IMUN” or the...
Read more
AIT Therapeutics Announces Further Data From Its NO-NTM Abscessus Phase 2 Clinical Trial in Nontuberculous Mycobacteria (NTM) Patients
Mycobacterium Abscessus Load Reduced by 65% NEW YORK, Jan. 22, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage...
Read more
Nemaura Medical Inc. Announces Uplisting to NASDAQ Capital Market on January 25, 2018
Jan 23, 2018 OTC Disclosure & News Service - Nemaura Medical Inc. (“Nemaura”) (OTCQB: NMRD), a medical technology company developing...
Read more
OptimizeRx Expands Exclusive Partnership with Allscripts for Prescription Cost Savings and Real-time Messaging at Point-of-Care
ROCHESTER, Mich., Jan. 09, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OTCQB:OPRX), the nation’s leading provider of digital health messaging, has expanded its...
Read more
HealthLynked Corp. Announces release of its Medical Newsfeed Service for Members and Providers
NAPLES, Fla., Jan. 02, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB:HLYK) today announced the release of its new design with the introduction...
Read moreCo-Diagnostics, Inc. Enters Into Lease for New, Upgraded Laboratory Facility
Laboratory will meet CGMP Requirements of FDA; Will be BSL-2 to allow enhanced in-house verification and validation activities SALT LAKE...
Read more
© Copyright 2022 publicwire.com